Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial
Year of publication
2023
Authors
Ray-Coquard, I.; Leary, A.; Pignata, S.; Cropet, C.; González-Martín, A.; Marth, C.; Nagao, S.; Vergote, I.; Colombo, N.; Mäenpää, J.; Selle, F.; Sehouli, J.; Lorusso, D.; Guerra Alia, E. M.; Bogner, G.; Yoshida, H.; Lefeuvre-Plesse, C.; Buderath, P.; Mosconi, A. M.; Lortholary, A.
Show moreOrganizations and authors
Tampere University
Mäenpää J.
Tampere University Hospital
Mäenpää J.
Publication type
Publication format
Article
Parent publication type
Journal
Article type
Original article
Audience
ScientificPeer-reviewed
Peer-ReviewedMINEDU's publication type classification code
A1 Journal article (refereed), original researchPublication channel information
Journal/Series
Volume
34
Issue
8
Pages
681-692
ISSN
Publication forum
Publication forum level
3
Open access
Open access in the publisher’s service
Yes
Open access of publication channel
Partially open publication channel
License of the publisher’s version
CC BY NC ND
Self-archived
Yes
License of the self-archived publication
CC BY NC ND
Other information
Fields of science
Cancers; Gynaecology and paediatrics
Internationality of the publisher
International
Language
English
International co-publication
Yes
Co-publication with a company
No
DOI
10.1016/j.annonc.2023.05.005
The publication is included in the Ministry of Education and Culture’s Publication data collection
Yes